International Journal of Infection

Published by: Kowsar

Diagnostic Value of the Quantitative Titer of High-Sensitivity C-Reactive Protein in the Detection of Clinical Stages of Chronic Hepatitis B Infection

Maliheh Metanat 1 , Seyed Mehdi Tabatabaei 1 , Anita Alenabi 1 , Mohamad Hasan Amirian Mojarad 1 , Nahid Sepehri Rad 1 , * and Elham Pahlavani 1
Authors Information
1 Infectious Diseases and Tropical Medicine Research Center, Zahedan University of Medical Sciences, Zahedan, IR Iran
Article information
  • International Journal of Infection: April 2017, 4 (2); e39736
  • Published Online: November 19, 2016
  • Article Type: Research Article
  • Received: July 5, 2016
  • Revised: November 6, 2016
  • Accepted: November 7, 2016
  • DOI: 10.5812/iji.39736

To Cite: Metanat M, Tabatabaei S M, Alenabi A, Amirian Mojarad M H, Sepehri Rad N, et al. Diagnostic Value of the Quantitative Titer of High-Sensitivity C-Reactive Protein in the Detection of Clinical Stages of Chronic Hepatitis B Infection, Int J Infect. 2017 ; 4(2):e39736. doi: 10.5812/iji.39736.

Copyright © 2016, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004; 11(2): 97-107[PubMed]
  • 2. Kumar M, Singh T, Sinha S. Chronic hepatitis B virus infection and pregnancy. J Clin Exp Hepatol. 2012; 2(4): 366-81[DOI][PubMed]
  • 3. Yalcin K, Degertekin H, Yildiz F, Celik Y. Markers of disease activity in chronic hepatitis B virus infection. Clin Invest Med. 2003; 26(1): 27
  • 4. Yuan LY, Ke ZQ, Wang M, Li Y. Procalcitonin and C-reactive protein in the diagnosis and prediction of spontaneous bacterial peritonitis associated with chronic severe hepatitis B. Ann Lab Med. 2013; 33(6): 449-54[DOI][PubMed]
  • 5. Hashemi-Shahri SM, Sharifi-Mood B, Khalili M. Review of the Prevention of the Hepatitis B Virus Infection Transmission From Mother to Child During Pregnancy. Int J Infect. 2015; 2(3)[DOI]
  • 6. Alian S, Masoudzadeh A, Khoddad T, Dadashian A, Ali Mohammadpour R. Depression in hepatitis B and C, and its correlation with hepatitis drugs consumption (interfron/lamivodin/ribaverin). Iran J Psychiatry Behav Sci. 2013; 7(1): 24-9[PubMed]
  • 7. Alavian SM. Hepatitis B is a Serious Health Problem in Some Parts of Iran; Sistan and Baluchestan Province. Int J Infect. 2015; 2(2)[DOI]
  • 8. Moudi B, Heidari Z, Mahmoudzadeh-Sagheb H, Hashemi M, Metanat M, Khosravi S, et al. Association Between IL-10 Gene Promoter Polymorphisms (-592 A/C, -819 T/C, -1082 A/G) and Susceptibility to HBV Infection in an Iranian Population. Hepat Mon. 2016; 16(2)[DOI][PubMed]
  • 9. Yilmaz S, Bayan K, Tuzun Y, Dursun M, Kaplan A, Ozmen S, et al. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis. Int J Clin Pract. 2007; 61(3): 438-43[DOI][PubMed]
  • 10. Zhang X, Zoulim F, Habersetzer F, Xiong S, Trepo C. Analysis of hepatitis B virus genotypes and pre-core region variability during interferon treatment of HBe antigen negative chronic hepatitis B. J Med Virol. 1996; 48(1): 8-16[DOI][PubMed]
  • 11. Al-Ajeeli KS. Assessment of C-reactive protein titer in patients with chronic hepatitis B virus infection. Iraqi J Comm Med. 2011; 24(4): 291-4
  • 12. Shima M, Nakao K, Kato Y, Nakata K, Ishii N, Nagataki S. Comparative study of C-reactive protein in chronic hepatitis B and chronic hepatitis C. Tohoku J Exp Med. 1996; 178(3): 287-97[PubMed]
  • 13. Gedik M, Ozekinci T, Ozbek E, Atmaca S, Yilmaz S. Lack of correlation between CRP and hepatitis B viral load in serum of patients with chronic HBV. J Infect. 2007; 54(2): 204[DOI][PubMed]
  • 14. She S, Xiang Y, Yang M, Ding X, Liu X, Ma L, et al. C-reactive protein is a biomarker of AFP-negative HBV-related hepatocellular carcinoma. Int J Oncol. 2015; 47(2): 543-54[DOI][PubMed]
  • 15. Heikkila K, Ebrahim S, Lawlor DA. A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Community Health. 2007; 61(9): 824-33[DOI][PubMed]
  • 16. McMahon BJ. Natural history of chronic hepatitis B - clinical implications. Medscape J Med. 2008; 10(4): 91[PubMed]
  • 17. Song LW, Liu PG, Liu CJ, Zhang TY, Cheng XD, Wu HL, et al. Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infection. Clin Microbiol Infect. 2015; 21(2): 197-203[DOI][PubMed]
  • 18. European Association For The Study Of The L. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol. 2012; 57(1): 167-85[DOI][PubMed]
  • 19. Liu XY, Ma LN, Yan TT, Lu ZH, Tang YY, Luo X, et al. Combined detection of liver stiffness and C-reactive protein in patients with hepatitis B virus-related liver cirrhosis, with and without hepatocellular carcinoma. Mol Clin Oncol. 2016; 4(4): 587-90[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments